CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 90 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.06 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,832,000 | +151.7% | 341,584 | +105.5% | 0.00% | 0.0% |
| Q4 2021 | $1,125,000 | +26.0% | 166,223 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $893,000 | -6.3% | 168,398 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $953,000 | -0.2% | 165,722 | -20.0% | 0.00% | 0.0% |
| Q1 2021 | $955,000 | +139.3% | 207,255 | +73.4% | 0.00% | – |
| Q4 2020 | $399,000 | +14.7% | 119,529 | +2.0% | 0.00% | – |
| Q3 2020 | $348,000 | -14.1% | 117,185 | +33.6% | 0.00% | – |
| Q2 2020 | $405,000 | +113.2% | 87,698 | +77.7% | 0.00% | – |
| Q1 2020 | $190,000 | -18.5% | 49,353 | -20.4% | 0.00% | – |
| Q4 2019 | $233,000 | +247.8% | 62,008 | +392.9% | 0.00% | – |
| Q3 2019 | $67,000 | -93.0% | 12,579 | -93.3% | 0.00% | -100.0% |
| Q1 2019 | $952,000 | -6.8% | 186,708 | -28.6% | 0.00% | 0.0% |
| Q4 2017 | $1,022,000 | – | 261,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |